Performant Healthcare CFO RSU vesting, tax withholding
Performant Healthcare Chief Financial Officer Rohit Ramchandani exercised 15,525 restricted stock units into common stock on August 14, 2025.
Rhea-AI Filing Summary
Performant Healthcare Chief Financial Officer Rohit Ramchandani exercised 15,525 restricted stock units into common stock on August 14, 2025. In a related tax-withholding disposition, 7,729 common shares were delivered at $7.61 per share. After these transactions he directly holds 271,892 common shares.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insider vested RSUs and used a share-surrender to satisfy taxes, modest net increase in held shares but reported beneficial ownership declined due to surrender.
The filing documents routine equity compensation activity rather than open-market trading. Fifteen thousand five hundred twenty-five restricted stock units vested and converted into the same number of common shares with no purchase price, consistent with standard employee equity compensation. Seven thousand seven hundred twenty-nine shares were surrendered to satisfy tax withholding obligations at $7.61 per share. Net change reduced reported beneficial ownership from 279,621 to 271,892 shares. This is a standard administrative transaction with limited market impact unless aggregated with other insider sales.
TL;DR: This is a routine Form 4 disclosing RSU vesting and tax withholding; it signals compensation realization, not a discretionary sale.
The report indicates the RSU award was granted on August 13, 2021 and vests in installments; the vested units reported here reflect scheduled vesting and tax-related share surrender. The filing includes the 10b5-1 box checked, suggesting at least one transaction may have been executed under a prearranged plan. All disclosures required by Section 16 are present and the signature certifies accuracy. Materiality to investors is low absent larger concurrent insider sales or company events.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 15,525 | $0.00 | $0.00 |
| Exercise | Common Stock, par value $0.0001 per share | 15,525 | $0.00 | $0.00 |
| Exercise Price or Tax Liability | Common Stock, par value $0.0001 per share | 7,729 | $7.61 | $59K |
Footnotes (3)
- F1. Shares surrendered to pay tax liability due on vesting of Restricted Stock Units
- F2. Each restricted stock unit represents a contingent right to receive one share of PHLT's common stock. The units were awarded at no cost to Reporting Person.
- F3. Restricted Stock Unit award was granted on August 13, 2021 (the "Grant Date"). The Restricted Stock Units will vest in four equal installments on the first day of the next open trading window immediately following the first, second, third and fourth anniversaries of the Grant Date provided that the Reporting Person remains in continuous service through each vest date, subject to vesting acceleration pursuant to the terms of the Reporting Person's Change in Control and Severance Agreement.
Key Figures
Key Terms
Restricted Stock Units financial
tax-withholding disposition financial
Change in Control and Severance Agreement financial
open trading window financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did PHLT's CFO report in this Form 4 insider filing?
How many restricted stock units did PHLT's CFO exercise on August 14, 2025?
What is Rohit Ramchandani's PHLT common stock holding after the Form 4?
When were PHLT's CFO restricted stock units granted and how do they vest?
AI-generated analysis. How Rhea-AI works. Not financial advice.